Bank of America’s Tango Therapeutics TNGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.84M Sell
327,144
-150,918
-32% -$2.1M ﹤0.01% 3226
2025
Q4
$4.24M Buy
478,062
+322,615
+208% +$2.78M ﹤0.01% 3518
2025
Q3
$1.31M Buy
155,447
+108,302
+230% +$733K ﹤0.01% 5150
2025
Q2
$241K Sell
47,145
-304,344
-87% -$753K ﹤0.01% 6092
2025
Q1
$482K Buy
351,489
+79,256
+29% +$195K ﹤0.01% 5666
2024
Q4
$841K Buy
272,233
+96,864
+55% +$450K ﹤0.01% 5179
2024
Q3
$1.35M Buy
175,369
+93,469
+114% +$892K ﹤0.01% 4853
2024
Q2
$703K Sell
81,900
-26,143
-24% -$202K ﹤0.01% 5123
2024
Q1
$858K Buy
108,043
+48,247
+81% +$517K ﹤0.01% 5020
2023
Q4
$592K Buy
59,796
+7,840
+15% +$68.1K ﹤0.01% 5371
2023
Q3
$585K Sell
51,956
-13,079
-20% -$79.8K ﹤0.01% 5220
2023
Q2
$216K Sell
65,035
-34,732
-35% -$125K ﹤0.01% 5780
2023
Q1
$394K Sell
99,767
-47,613
-32% -$276K ﹤0.01% 5537
2022
Q4
$1.07M Buy
147,380
+51,222
+53% +$360K ﹤0.01% 4804
2022
Q3
$348K Buy
96,158
+15,714
+20% +$67.1K ﹤0.01% 5642
2022
Q2
$364K Buy
80,444
+543
+0.7% +$3.29K ﹤0.01% 5655
2022
Q1
$606K Sell
79,901
-13,977
-15% -$121K ﹤0.01% 5686
2021
Q4
$1.03M Buy
93,878
+93,848
+312,827% +$1.13M ﹤0.01% 5211
2021
Q3
$0 Buy
+30
New +$360 ﹤0.01% 8393
2020
Q4
Sell
-832
Closed -$9K 7366
2020
Q3
$9K Buy
+832
New +$8.5K ﹤0.01% 6479

Other funds holding TNGX

Bank of America's TNGX Position: Q1 2026 in Review

Bank of America reduced its Tango Therapeutics (TNGX) stake by 32% in Q1 2026, selling an estimated $2.1M and leaving 327,144 shares worth $6.84M. The position accounts for ﹤0.01% of the portfolio, ranked #3226.

Bank of America first reported a position in TNGX in Q3 2020 and has held it in 20 quarters since. 194 funds tracked by Wall St. Rank hold TNGX as of Q1 2026.

  • Bank of America held 327,144 shares of Tango Therapeutics worth $6.84M as of Q1 2026.
  • Bank of America sold 150,918 Tango Therapeutics shares in Q1 2026, an estimated $2.1M.
  • Tango Therapeutics made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #3226 holding.
  • Bank of America first reported a position in Tango Therapeutics in Q3 2020 and has held it in 20 quarters since.
  • 194 funds tracked by Wall St. Rank held Tango Therapeutics as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.